This is just the third time our international community has formally met. We are consequently a very young field and there are important questions that need to be addressed as a group. One goal of the current meeting is to begin to develop (1) definitions related to CLE, (2) diagnostic criteria for CLE that allow diagnosis of a specific type of CLE or lupus-associated skin lesion, and (3) subsequently begin the process of evaluating and developing a classification for CLE and that incorporates the most recent scientific developments in the field. This is important so that we communicate with the same terminology within our field, as well as with other specialities that evaluate and care for patients with lupus. Clear definitions and criteria related to CLE will facilitate clinical and research studies in the field. In rheumatology, OMERACT has utilized the Delphi technique to allow input from the diverse members of a scientific community to have an equal voice in determining the components that can be then voted on iteratively, with the final goal to develop a product (diagnostic and classification criteria) that can be further tested in live patients, then further refined. This is a model that could be applied to other areas of autoimmune skin disease, including dermatomyositis, vasculitis, and morphea/scleroderma. It is thus important to give careful consideration of the methodology for beginning this approach.
giovedý 24 aprile 2014